Risultati della ricerca - Benjamin Scheier
- Mostra 1 - 3 risultati su 3
-
1
Metastatic Merkel cell carcinoma response to nivolumab di Frances M. Walocko, Benjamin Scheier, Paul W. Harms, Leslie A. Fecher, Christopher D. Lao
Pubblicazione 2016Artigo -
2
Stereotactic Radiation Therapy can Safely and Durably Control Sites of Extra-Central Nervous System Oligoprogressive Disease in Anaplastic Lymphoma Kinase-Positive Lung Cancer Pati... di Gregory N. Gan, Andrew Weickhardt, Benjamin Scheier, Robert C. Doebele, Laurie E. Gaspar, Brian D. Kavanagh, D. Ross Camidge
Pubblicazione 2014Artigo -
3
Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer di Andrew Weickhardt, Benjamin Scheier, Joseph Burke, Gregory N. Gan, Xian Lu, Paul A. Bunn, Dara L. Aisner, Laurie E. Gaspar, Brian D. Kavanagh, Robert C. Doebele, D. Ross Camidge
Pubblicazione 2012Artigo
Strumenti per la ricerca:
Soggetti correlati
Internal medicine
Medicine
Oncology
Cancer
Cancer research
Crizotinib
Lung cancer
Malignant pleural effusion
Anaplastic lymphoma kinase
Antibody
Avelumab
Carcinoma
Chemotherapy
Epidermal growth factor receptor
Erlotinib
Erlotinib Hydrochloride
Gefitinib
Immunology
Immunotherapy
Lesion
Malignancy
Merkel cell carcinoma
Monoclonal antibody
Nivolumab
Progression-free survival
Radiation therapy
Receptor
Surgery
Tumor progression
Tyrosine kinase